Biobanks Market – Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2017-2027 Segmented By Type (Disease Oriented Biobanks, Population Based Biobanks, Tissue Biobanks, Others), By Sample Type (Blood Products, Biological Fluids, Nucleic Acid, Cell Lines, Others), By Application (Therapeutics, Drug Discovery, Clinical Diagnostics, Clinical Research), By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Others), By Region

  • Industry : Healthcare
  • |
  • Pages : 110
  • |
  • Published Date : July, 2022
Customization Enquiry

Buy Now

Summary

Report Description

The Global Biobanks Market stood at USD40.70 billion in 2021 and is expected to grow at an impressive rate of 8.22% during the forecast period. This can be ascribed to the growing investments and research & development in advanced therapies such as cancer genomic studies, personalized medicine, among others.

Biobanks play a pivotal role in disease diagnosis and development of a treatment or drug. The COVID-19 pandemic crisis has significantly increased the demand for biobanks worldwide. During the pandemic crisis various new specialized biobanks, focusing on COVID-19 were developed for research & development activities. For instance, in July 2021, Tulane University announced a new COVID-19 biobank containing blood & cell samples from survivors.  

Regenerative Medicine Applications for Biobanking Market will drive the Market

Biobanks Market contributes to the advancement of biomedical and translational research by collecting and preserving biological samples such as blood, tissues, and nucleic acids, which are then made available for use in research to discover disease-relevant biomarkers; this information is then used for diagnosis, prognosis, and drug response prediction. The increase in the number of research activities in this area is a major market driver. The availability of government financing for regenerative medicine, stem cell treatments, and cell and gene therapy are fueling this segment's research. Aside from that, the growing trend of cord blood banking will help this market segment develop. Future possibilities are predicted to include breakthroughs in orthopaedic therapies utilising stem cells.

Stakeholders Shifting Focus from Sample-driven to Data-driven Strategies

Precision medicine research is gaining traction as a result of the digital revolution. Precision medicine research and clinical data are also inextricably linked. Although there are times when there are modest connections between the two variables. Because the availability of data on well-characterized and high-quality samples is of relevance to healthcare organizations, this works as a profitable opportunity for stakeholders in the biobanking market.

Artificial intelligence (AI) and big data analytics are being introduced into the biobanking landscape in order to develop strong correlations between precision medicine research and clinical data. This has aided faster research, which has had a positive impact on the delivery of new pharmaceuticals in the healthcare industry. As a result, there is a growing demand in the biobanking industry for increased informatics capabilities.

Demand for Temperature Control Systems to Gain Strength in Biobanks Market

 Biobanks are in high demand to preserve a variety of biospecimen, from blood to tissues, cells, and nucleic acids, due to the growing trend of personalized treatments to reduce chronic disease-related mortality rates.

As major manufacturers are focusing their efforts on the release of freezers and refrigerators, cryogenic storage systems, and other equipment for the storage of biobank samples, the market is expected to place a greater emphasis on temperature control systems, boosting global demand for Biobanks. The equipment segment is being driven by an increase in the number of Biobanks in several countries, as well as a desire for sophisticated biobanking equipment.


DOWNLOAD FREE SAMPLE REPORT

Market Segmentation

The Global Biobanks Market is segmented based on Type, Sample Type, Application, End User, Region, and by Company. Based on Type, the market is further fragmented into Disease Oriented Biobanks, Population Based Biobanks, Tissue Biobanks and Others. Based on Sample Type, the market is segmented into Blood Products, Biological fluids, Nucleic Acid, Cell Lines and Others. Also, segmentation of the market based on the Application is done into Therapeutics, Drug Discovery, Clinical Diagnostic and Clinical Research.  Based on End User, the market is further fragmented into Academic & Research Institutes, Pharma & Biotech Companies, Hospitals & Clinics and Others. The market analysis also studies the regional segmentation divided among North American region, Asia-Pacific region, European region, Middle East & African region, South American region. The North America dominated the market in 2021 and is projected to maintain its dominance during the forecast period. United States market for biobanks was the largest and stood at USD9.03 billion in 2021. This can be ascribed to the large number of biobanks establishments in the country.

Company Profiles

Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Avantor, Inc., Thermo Fisher Scientific, Inc, Tecan Trading AG, QIAGEN N.V. Hamilton Company, ProMedDx, LLC, ISENET Biobanking S.r.l., are among the major market players in the Global Biobanks Market.

Attribute

Details

Market size value in 2021

USD 40.70 Billion

Revenue Forecast in 2027

USD 66.19 Billion

United States Market size value in 2021

USD 9.03 Billion

Growth Rate

8.22%

Base Year

2021

Historical Years

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Billion, and CAGR for 2017-2021 and 2022E-2027F

Report Coverage

·         Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

·         Type

·         Sample Type

·         Application

·         End User

Regional Scope

North America; Europe; Asia-Pacific; Middle East & Africa; South America.

Country Scope

United States; Canada; Mexico; Italy; France; Germany; United Kingdom; Spain; China; Australia; India; South Korea; Japan; Brazil; Colombia; Argentina; Saudi Arabia; UAE; South Africa.

Key Companies Profiled

Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Avantor, Inc., Thermo Fisher Scientific, Inc, Tecan Trading AG, QIAGEN N.V. Hamilton Company, ProMedDx, LLC, ISENET Biobanking S.r.l

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/pdf format on special request)

 

Report Scope:

In this report, global biobanks market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Biobanks Market, By Type:

o   Disease Oriented Biobanks

o   Population Based Biobanks

o   Tissue Biobanks

o   Others

·         Global Biobanks Market, By Sample Type

    • Blood Products
    • Biological fluids
    • Nucleic Acid
    • Cell Lines
    • Others
  • Global Biobanks Market, By Application:
    • Therapeutics
    • Drug Discovery
    • Clinical Diagnostics
    • Clinical Research
  • Global Biobanks Market, By End User:
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Clinics
    • Others

·         Global Biobanks Market, By Region:

    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Italy
      • France
      • Germany
      • United Kingdom
      • Spain
    • Asia Pacific
      • China
      • Australia
      • India
      • South Korea
      • Japan
    • South America
      • Brazil
      • Colombia
      • Argentina
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Biobanks Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report: 

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Biobanks Market

5.    Voice of Customer

5.1.  Factors Contributing to Demand for Biobanks

5.2.  Source of Information

5.3.  Preference for Biobanks, By Type

5.4.  Unmet Needs/Challenges

6.    Global Biobanks Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Disease Oriented Biobanks, Population Based Biobanks, Tissue Biobanks, Others)

6.2.2.     By Sample Type (Blood Products, Biological fluids, Nucleic Acid, Cell Lines, Others

6.2.3.     By Application ( Therapeutics, Drug Discovery, Clinical Diagnostics, Clinical Research

6.2.4.     By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Clinics, Others)

6.2.5.     By Company (2021)

6.2.6.     By Region

6.3.  Product Market Map

7.    North America Biobanks Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type

7.2.2.     By Sample Type

7.2.3.     By Application

7.2.4.     By End User

7.2.5.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Biobanks Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Type

7.3.1.2.2.             By Sample Type

7.3.1.2.3.             By Application

7.3.1.2.4.             By End User

7.3.2.     Canada Biobanks Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Type

7.3.2.2.2.             By Sample Type

7.3.2.2.3.             By Application

7.3.2.2.4.             By End User

7.3.3.     Mexico Biobanks Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value & Volume

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Type

7.3.3.2.2.             By Sample Type

7.3.3.2.3.             By Application

7.3.3.2.4.             By End User

8.    Europe Biobanks Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type

8.2.2.     By Sample Type

8.2.3.     By Application

8.2.4.     By End User

8.2.5.     By Country

8.3.  Europe: Country Analysis

8.3.1.     Italy Biobanks Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Type

8.3.1.2.2.             By Sample Type

8.3.1.2.3.             By Application

8.3.1.2.4.             By End User

8.3.2.     France Biobanks Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Type

8.3.2.2.2.             By Sample Type

8.3.2.2.3.             By Application

8.3.2.2.4.             By End User

8.3.3.     Germany Biobanks Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Type

8.3.3.2.2.             By Sample Type

8.3.3.2.3.             By Application

8.3.3.2.4.             By End User

8.3.4.     United Kingdom Biobanks Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Type

8.3.4.2.2.             By Sample Type

8.3.4.2.3.             By Application

8.3.4.2.4.             By End User

8.3.5.     Spain Biobanks Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Type

8.3.5.2.2.             By Sample Type

8.3.5.2.3.             By Application

8.3.5.2.4.             By End User

9.    Asia-Pacific Biobanks Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type

9.2.2.     By Sample Type

9.2.3.     By Application

9.2.4.     By End User

9.2.5.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Biobanks Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type

9.3.1.2.2.             By Sample Type

9.3.1.2.3.             By Application

9.3.1.2.4.             By End User

9.3.2.     Australia Biobanks Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type

9.3.2.2.2.             By Sample Type

9.3.2.2.3.             By Application

9.3.2.2.4.             By End User

9.3.3.     India Biobanks Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type

9.3.3.2.2.             By Sample Type

9.3.3.2.3.             By Application

9.3.3.2.4.             By End User

9.3.4.     South Korea Biobanks Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Type

9.3.4.2.2.             By Sample Type

9.3.4.2.3.             By Application

9.3.4.2.4.             By End User

9.3.5.     Japan Biobanks Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Type

9.3.5.2.2.             By Sample Type

9.3.5.2.3.             By Application

9.3.5.2.4.             By End User

10.  South America Biobanks Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type

10.2.2.  By Sample Type

10.2.3.  By Application

10.2.4.  By End User

10.2.5.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Biobanks Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type

10.3.1.2.2.           By Sample Type

10.3.1.2.3.           By Application

10.3.1.2.4.           By End User

10.3.2.  Colombia Biobanks Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type

10.3.2.2.2.           By Sample Type

10.3.2.2.3.           By Application

10.3.2.2.4.           By End User

10.3.3.  Argentina Biobanks Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type

10.3.3.2.2.           By Sample Type

10.3.3.2.3.           By Application

10.3.3.2.4.           By End User

11.  Middle East and Africa Biobanks Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Product Type

11.2.2.  By Category

11.2.3.  By Application

11.2.4.  By End User

11.2.5.  By Country

11.3.              MEA: Country Analysis

11.3.1.  Saudi Arabia Biobanks Markets Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Type

11.3.1.2.2.           By Sample Type

11.3.1.2.3.           By Application

11.3.1.2.4.           By End User

11.3.2.  UAE Biobanks Markets Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Type

11.3.2.2.2.           By Sample Type

11.3.2.2.3.           By Application

11.3.2.2.4.           By End User

11.3.3.  South Africa Biobanks Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Type

11.3.3.2.2.           By Sample Type

11.3.3.2.3.           By Application

11.3.3.2.4.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Danaher Corporation

14.2.              Merck KGaA

14.3.              Becton, Dickinson, and Company

14.4.              Avantor, Inc.

14.5.              Thermo Fisher Scientific, Inc

14.6.              Tecan Trading AG

14.7.              QIAGEN N.V.

14.8.              Hamilton Company

14.9.              ProMedDx, LLC

14.10.            ISENET Biobanking S.r.l

15.  Strategic Recommendations

16.  About Us & Disclaimer

Figures and Tables

Figure 1: Global Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 2: Global Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 3: Global Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 4: Global Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 5: Global Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 6: Global Biobanks Market Share, By Region, By Value, 2017-2027F

Figure 7: Global Biobanks Market Share, By Company, 2021

Figure 8: Global Biobanks Market Map, By Type, Market Size (USD Billion) & Growth Rate (%), 2021

Figure 9: Global Biobanks Market Map, By Sample Type, Market Size (USD Billion) & Growth Rate (%), 2021

Figure 10: Global Biobanks Market Map, By Application, Market Size (USD Billion) & Growth Rate (%), 2021

Figure 11: Global Biobanks Market Map, By End User, Market Size (USD Billion) & Growth Rate (%), 2021

Figure 12: Global Biobanks Market Map, By Region, Market Size (USD Billion) & Growth Rate (%), 2021

Figure 13: North America Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 14: North America Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 15: North America Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 16: North America Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 17: North America Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 18: North America Biobanks Market Share, By Country, By Value, 2017-2027F

Figure 19: United States Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 20: United States Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 21: United States Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 22: United States Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 23: United States Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 24: Canada Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 25: Canada Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 26: Canada Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 27: Canada Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 28: Canada Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 29: Mexico Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 30: Mexico Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 31: Mexico Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 32: Mexico Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 33: Mexico Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 34: Europe Biobank Market Size, By Value (USD Billion), 2017-2027F

Figure 35: Europe Biobank Market Share, By Type, By Value, 2017-2027F

Figure 36: Europe Biobank Market Share, By Sample Type, By Value, 2017-2027F

Figure 37: Europe Biobank Market Share, By Application, By Value, 2017-2027F

Figure 38: Europe Biobank Market Share, By End User, By Value, 2017-2027F

Figure 39: Europe Biobanks Market Share, By Country, By Value, 2017-2027F

Figure 40: Italy Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 41: Italy Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 42: Italy Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 43: Italy Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 44: Italy Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 45: France Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 46: France Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 47: France Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 48: France Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 49: France Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 50: Germany Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 51: Germany Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 52: Germany Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 53: Germany Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 54: Germany Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 55: United Kingdom Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 56: United Kingdom Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 57: United Kingdom Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 58: United Kingdom Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 59: United Kingdom Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 60: Spain Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 61: Spain Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 62: Spain Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 63: Spain Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 64: Spain Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 65: Asia Pacific Biobank Market Size, By Value (USD Billion), 2017-2027F

Figure 66: Asia Pacific Biobank Market Share, By Type, By Value, 2017-2027F

Figure 67: Asia Pacific Biobank Market Share, By Sample Type, By Value, 2017-2027F

Figure 68: Asia Pacific Biobank Market Share, By Application, By Value, 2017-2027F

Figure 69: Asia Pacific Biobank Market Share, By End User, By Value, 2017-2027F

Figure 70: Asia Pacific Biobanks Market Share, By Country, By Value, 2017-2027F

Figure 71: China Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 72: China Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 73: China Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 74: China Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 75: China Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 76: Australia Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 77: Australia Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 78: Australia Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 79: Australia Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 80: Australia Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 81: India Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 82: India Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 83: India Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 84: India Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 85: India Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 86: South Korea Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 87: South Korea Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 88: South Korea Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 89: South Korea Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 90: South Korea Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 91: Japan Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 92: Japan Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 93: Japan Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 94: Japan Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 95: Japan Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 96: South America Biobank Market Size, By Value (USD Billion), 2017-2027F

Figure 97: South America Biobank Market Share, By Type, By Value, 2017-2027F

Figure 98: South America Biobank Market Share, By Sample Type, By Value, 2017-2027F

Figure 99: South America Biobank Market Share, By Application, By Value, 2017-2027F

Figure 100: South America Biobank Market Share, By End User, By Value, 2017-2027F

Figure 101: South America Biobanks Market Share, By Country, By Value, 2017-2027F

Figure 102: Brazil Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 103: Brazil Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 104: Brazil Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 105: Brazil Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 106: Brazil Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 107: Colombia Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 108: Colombia Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 109: Colombia Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 110: Colombia Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 111: Colombia Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 112: Argentina Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 113: Argentina Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 114: Argentina Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 115: Argentina Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 116: Argentina Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 117: Middle East and Africa Biobank Market Size, By Value (USD Billion), 2017-2027F

Figure 118: Middle East and Africa Biobank Market Share, By Type, By Value, 2017-2027F

Figure 119: Middle East and Africa Biobank Market Share, By Sample Type, By Value, 2017-2027F

Figure 120: Middle East and Africa Biobank Market Share, By Application, By Value, 2017-2027F

Figure 121: Middle East and Africa Biobank Market Share, By End User, By Value, 2017-2027F

Figure 122: Middle East and Africa Biobanks Market Share, By Country, By Value, 2017-2027F

Figure 123: Saudi Arabia Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 124: Saudi Arabia Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 125: Saudi Arabia Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 126: Saudi Arabia Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 127: Saudi Arabia Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 128: UAE Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 129: UAE Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 130: UAE Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 131: UAE Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 132: UAE Biobanks Market Share, By End User, By Value, 2017-2027F

Figure 133: South Africa Biobanks Market Size, By Value (USD Billion), 2017-2027F

Figure 134: South Africa Biobanks Market Share, By Type, By Value, 2017-2027F

Figure 135: South Africa Biobanks Market Share, By Sample Type, By Value, 2017-2027F

Figure 136: South Africa Biobanks Market Share, By Application, By Value, 2017-2027F

Figure 137: South Africa Biobanks Market Share, By End User, By Value, 2017-2027F

Frequently asked questions

down-arrow

The market size of the Global Biobanks Market is expected to grow at a CAGR of 8.22% and reach USD66.19 billion by 2027. This can be ascribed to the growing demand for preserving cord blood stem cells worldwide.

down-arrow

Biobanks widely used in variety of applications but dominating segment is in therapeutics purposes. Therapeutic application in Biobank is increased due to progress in personalized medicine and that also promotes the development of genetic research, therefore the therapeutic application segment held the largest market share of 54.48% for the base year 2021.

down-arrow

Asia Pacific is the fastest growing region in the Global Biobanks Market on account of growing number of biobanks in countries like China, Australia and India.

down-arrow

Increase in demand for biospecimens from clinical labs to develop assays for genetic testing and the increasing popularity of precision/personalized medicine and genetic testing has been a key driver of the markets are the major drivers for the Global Biobanks Market.

Related Reports

profile

Sakshi Bajaal

Principal Consultant
Press Release

Biobanks Market to Surpass USD66.19 Billion by 2027

Jul, 2022

COVID-19 samples are collected and stored in Biobanks for future use in the development of validated diagnostics, vaccines, and therapies, which will fuel the growth of Global Biobanks Market in the

Why Choose Us